Thank you for writing to us. One of our executive will reach back to you through your submitted medium. In case there’s an urgency, feel free to connect over WhatsApp for faster response.
Prefer calling? Dial +9108048030295 (International callers) or 08048030295 (Indian callers).
CINKONA 300 MG 100 TAB QUININE SULPHATE
₹ 600 / Strip Get Latest Price
Product Brochure
Strength 300 mg
Packaging Size 1*10
Prescription/Non prescription Prescription
Form Tablet
Shelf life 24 Months
Country of Origin Made in India
CINKONA 300MG TABLET contains Quinine which belongs to the group of medicines called Antimalarials. It is used to treat malaria
Cinkona 300mg Tablet is an antiparasitic medicine, used for the treatment of malaria. It may also be used to treat and prevent nighttime leg cramps. It works by killing the malaria-causing parasite and stops the infection from spreading
Guaranteed Delivery
No Need Of Prescription
Traceable Tracking will be provided on confirmed purchase
Effective Pricing and Quality
Best store for Cinkona 300mg
Oral Semaglutide Tablets For Weight Loss 3mg 7mg 14mg Tablets
Get Best Quote
Request Callback
₹ 3149 / Pack Get Latest Price
Product Brochure
Form Tablets
Packaging Type Box
Composition Semaglutide
Packaging Size 1 X 10
Brand RYBELSUS
Manufacturer NOVO NORDISK
Shelf Life 24 Months
Usuage to treat type 2 diabetes
Prescription / Non Prescription Prescription
Usage WEIGHT LOSS
RYBELSUS® (semaglutide) tablets 3mg, 7 mg or 14 mg is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes.
It is not known if RYBELSUS® can be used in people who have had pancreatitis
RYBELSUS® is not for use in people with type 1 diabetes
It is not known if RYBELSUS® is safe and effective for use in children under 18 years of age
Key takeaways:
Rybelsus (semaglutide) is an oral medication approved to treat Type 2 diabetes. It contains the same active ingredient as Ozempic and Wegovy. Ozempic is approved for Type 2 diabetes, and Wegovy is approved for chronic weight management.
Rybelsus is currently being studied for weight loss in clinical trials. These studies involve higher doses than what’s currently approved and available for diabetes.
Results show that an oral semaglutide (Rybelsus) dose of 50 mg results in similar weight loss as Wegovy. Due to these findings, Rybelsus’ manufacturer plans to request FDA approval in 2023. If approved for weight loss, it may be marketed under a different brand name.
Yes! I am interested
Rybelsus Semaglutide 3Mg 7Mg 14Mg Tablets
Get Best Quote
Request Callback
₹ 2900 / Stripe Get Latest Price
Product Brochure
Form Tablets
Packaging size 10*10 Tablets
Packaging Type Strip
Composition Semaglutide
Brand Rybelsus
Shelf Life 24 Months
Usuage to treat type 2 diabetes
Prescription / Non Prescription Prescription
strength 3 mg
RYBELSUS® (semaglutide) tablets 3mg, 7 mg or 14 mg is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes.
It is not known if RYBELSUS® can be used in people who have had pancreatitis
RYBELSUS® is not for use in people with type 1 diabetes
It is not known if RYBELSUS® is safe and effective for use in children under 18 years of age
Key takeaways:
Rybelsus (semaglutide) is an oral medication approved to treat Type 2 diabetes. It contains the same active ingredient as Ozempic and Wegovy. Ozempic is approved for Type 2 diabetes, and Wegovy is approved for chronic weight management.
Rybelsus is currently being studied for weight loss in clinical trials. These studies involve higher doses than what’s currently approved and available for diabetes.
Results show that an oral semaglutide (Rybelsus) dose of 50 mg results in similar weight loss as Wegovy. Due to these findings, Rybelsus’ manufacturer plans to request FDA approval in 2023. If approved for weight loss, it may be marketed under a different brand name.
Yes! I am interested
Victoza Liraglutide Injection
Get Best Quote
Request Callback
₹ 4800 / Piece Get Latest Price
Product Brochure
Strength 6 mg/ ml
Packaging Type Vial
Brand Victozoa
Usage / Application Personal
Shelf Life 24 Months
Country of Origin Made in India
Liraglutide injection (Victoza) is used with a diet and exercise program to control blood sugar levels in adults and children 10 years of age and older with type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) when other medications
Yes! I am interested
BEMPIFY 180MG 100 TAB BEMPEDOIC ACID
Get Best Quote
Request Callback
₹ 100 / Stripe Get Latest Price
Product Brochure
Packaging Size 10*10 Tablets
Packaging Type Stripe
Strength 180 mg
Brand BEMPIFY 180MG
Country of Origin Made in India
Bempify Tablet 180mg is used to lower cholesterol and reduce the risk of heart disease. Cholesterol is a fatty substance that builds up in your blood vessels and causes narrowing, possibly leading to a heart attack or stroke.
Yes! I am interested
Mounjaro Tirzepatide 5mg/0.5ml Injection
Get Best Quote
Request Callback
₹ 5999 / Vial Get Latest Price
Product Brochure
Strength 5 mg
Packaging Size 0.5 ml
Packaging Type Injection
Brand Maunjaro
Manufacturer Eli Lilly and Company India Pvt Ltd
Prescription No
Usage / Application Management of Obesity
Mounjaro 5mg Solution for Injection is a prescription medicine used to improve blood sugar control in adults with type 2 diabetes and support weight management in individuals who are overweight and those with obesity. It works by mimicking natural hormones to enhance insulin secretion and regulate appetite.
Mounjaro 5mg Solution for Injection is administered once weekly subcutaneously in the abdomen, thigh, or upper arm. To maximize its benefits, maintain a consistent injection schedule and complement treatment with a healthy diet and regular exercise. Follow your doctor’s instructions carefully, including any dose adjustments, and store the me
Hydroxychloroquine 400
Hydroxychloroquine is in a class of drugs called antimalarials and is also an antirheumatic drug. It works by killing the organisms that cause malaria. Hydroxychloroquine may work to treat rheumatoid arthritis and systemic lupus erythematosus by decreasing the activity of the immune system.
Hydroxychloroquine is in a class of drugs called antimalarials and is also an antirheumatic drug. It works by killing the organisms that cause malaria. Hydroxychloroquine may work to treat rheumatoid arthritis and systemic lupus erythematosus by decreasing the activity of the immune system.
Adefovir is used to treat chronic (long-term) hepatitis B virus (HBV) infection in patients who are at least 12 years of age. Adefovir is not a cure for the hepatitis B virus, but it may lower the amount of virus in your body. It may also lower the ability of the virus to multiply in your body.
Artesunate belongs to a group of medicines known as antimalarials. It treats malaria, a red blood cell infection transmitted by the bite of a mosquito. However, this medicine is not used to prevent malaria. This medicine is to be given only by or under the immediate supervision of your doctor.
Ivermectin 12mg Stromectol Tablet for humans
₹ 149 / Box Get Latest Price
Dosage 3mg, 6mg, 12mg
Packaging Type Alu-Alu
Manufacturer Name Johnlee, signature, Jeerima
Prescription Required Yes
Composition (Salts) IVERMECTIN
Usages Antiparasite
Storage Conditions Room Temperature
Brand IVERJOHN
Ivermectin (Stromectol) is a medication used for infections caused by certain parasitic worms found in rural tropical areas. Depending on the type of worm being treated, serious side effects can occur. It hasn't been shown to work well for other types of infections.
ivermectin for humans 12mg Tablet
₹ 50 / Stripe Get Latest Price
Strength 12mg
Packaging Type Strip
Prescription Required Yes
Composition (Salts) Ivermectin
Usages Covid 19
Although vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), have been developed and distributed, major challenges remain regarding vaccine production and allocation.1 The identification of inexpensive, widely available, and effective therapies against Covid-19 is of great importance. The repurposing of existing medicines that are widely available and that have reasonably well understood safety profiles has appeal.2
One drug that has received considerable public use and interest is ivermectin, which is typically used as an antiparasitic drug. Ivermectin inhibits the chloride channels of helminthic parasites and has been shown to have clinical efficacy for the treatment of onchocerciasis, strongyloidiasis, and ectoparasitic infection (e.g., scabies).3 The in vitro antiviral activity of ivermectin has been explored against a spectrum of viruses, including severe acute respiratory syndrome coronavirus 1, human immunodeficiency virus, dengue virus, Zika virus, yellow fever virus, West Nile virus, Hendra virus, chikungunya virus, Semliki Forest virus, Sindbis virus, and avian influenza virus.4
More than 60 randomized trials of ivermectin for the treatment of Covid-19 have been registered, and findings have been reported for as many as 31 clinical trials.5 The results have been discordant, and various review groups interpret the evidence differently — some advocating for benefits of ivermectin, and others reticent to conclude a benefit.6-8 However, most trials have been small, and several have been withdrawn from publication owing to concerns about credibility.9
To evaluate the efficacy of ivermectin for the prevention of progression of Covid-19 resulting in hospitalization among outpatients with SARS-CoV-2 infection, we conducted a randomized, placebo-controlled, adaptive platform trial (TOGETHER) in the state of Minas Gerais, Brazil. Although various interventions were assessed in this trial, we report here on the use of ivermectin at a dose of 400 μg per kilogram of body weight for 3 days as compared with placebo.
iveremectin Ivecop 6 Mg Tablet
₹ 35 / Stripe Get Latest Price
Strength 6mg
Packaging Type Strip
Prescription Required Yes
Composition (Salts) Ivermectin
Usages Covid 19
Although vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), have been developed and distributed, major challenges remain regarding vaccine production and allocation.1 The identification of inexpensive, widely available, and effective therapies against Covid-19 is of great importance. The repurposing of existing medicines that are widely available and that have reasonably well understood safety profiles has appeal.2
One drug that has received considerable public use and interest is ivermectin, which is typically used as an antiparasitic drug. Ivermectin inhibits the chloride channels of helminthic parasites and has been shown to have clinical efficacy for the treatment of onchocerciasis, strongyloidiasis, and ectoparasitic infection (e.g., scabies).3 The in vitro antiviral activity of ivermectin has been explored against a spectrum of viruses, including severe acute respiratory syndrome coronavirus 1, human immunodeficiency virus, dengue virus, Zika virus, yellow fever virus, West Nile virus, Hendra virus, chikungunya virus, Semliki Forest virus, Sindbis virus, and avian influenza virus.4
More than 60 randomized trials of ivermectin for the treatment of Covid-19 have been registered, and findings have been reported for as many as 31 clinical trials.5 The results have been discordant, and various review groups interpret the evidence differently — some advocating for benefits of ivermectin, and others reticent to conclude a benefit.6-8 However, most trials have been small, and several have been withdrawn from publication owing to concerns about credibility.9
To evaluate the efficacy of ivermectin for the prevention of progression of Covid-19 resulting in hospitalization among outpatients with SARS-CoV-2 infection, we conducted a randomized, placebo-controlled, adaptive platform trial (TOGETHER) in the state of Minas Gerais, Brazil. Although various interventions were assessed in this trial, we report here on the use of ivermectin at a dose of 400 μg per kilogram of body weight for 3 days as compared with placebo.